Lannett reported $88.11M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Amerisourcebergen ABC:US USD 62.21B 1.48B
Ani Pharmaceuticals ANIP:US USD 88.82M 2.05M
Aurora Cannabis Inc ACB:CN CAD 103.76M 571.03M
Canopy Growth Corp WEED:CN CAD 277.53M 1.69B
Cardinal Health CAH:US USD 51.59B 2.12B
Corcept Therapeutics CORT:US USD 69.79M 2.16M
Depomed DEPO:US USD 27.78M 3.44M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Knight Therapeutics Inc GUD:CN CAD 83.61M 10.69M
Ligand Pharmaceuticals LGND:US USD 65.45M 9.36M
Mckesson MCK:US USD 69.25B 216M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Novartis NVS:US USD 11.05B 378M
Omeros OMER:US USD 50.77M 13.33M
Pacira Pharmaceuticals PCRX:US USD 146.18M 8M
Perrigo Ordinary Shares PRGO:US USD 1.07B 71.2M
Pfizer PFE:US USD 19.12B 5.9B
Prestige Brands PBH:US USD 188.34M 16.55M
Supernus Pharmaceuticals SUPN:US USD 178.88M 20.17M
Teva Pharmaceutical TEVA:IT USD 3.18B 1.56B
Zoetis ZTS:US USD 1.34B 47M